Zoledronic acid enhances the antitumor efficacy of the PSMA CAR-T cells for bone tumors, but impedes the ability to control metastases of prostate cancer in mice. - Li D; Gu X; Li J; Huang Y; Zhou WL; Wang F; Yan F; Gao H; Ying X; Li Y; Qi S; Zhu Y; et al. (Cancer gene therapy, 2026)